Here we introduce a novel SPC, named Very Short Peripheral Catheter(VSPC), that was designed to minimize biomechanical irritation and improve blood flow” Weiss et al (2018).
BACKGROUND: Short peripheral catheters (SPCs) are the most common intravenous device in today’s medical practice. Short peripheral catheter thrombophlebitis (SPCT) occurs in up to 80% of hospitalized patients. symptoms appear on average 3 days after catheter insertion and can lead to extended hospitalization and increased related costs. Here we introduce a novel SPC, named Very Short Peripheral Catheter(VSPC), that was designed to minimize biomechanical irritation and improve blood flow.
OBJECTIVE: The goal was to test the performance of the novel catheter in-vivo for reduction of thrombophlebitis.
METHODS: VSPC prototypes were inserted into swine ear veins (n=12). Verification to the catheter conformation in-situ, and blood perfusion was performed using Echo-Doppler. SPCT development rate was measured using MRI 4 and 12 days after catheter insertion, and analyzed by means of edema and inflammation intensities. Blind histopathology analysis was performed on the veins post-mortem. Clinically-available SPC was used as a reference.
RESULTS: Operation of the VSPC devices did not require any special skills over what is used to for the clinically-used SPC. Echo-Doppler imaging confirmed that in contrast to the traditional SPC, the VSPC avoided contact with the vein wall and allowed better blood perfusion. The MRI analysis revealed twice-fold inflammation and edema rates (~80%) in the veins cannulated with the commercial SPC, while only ~40% were evidenced for the novel VSPC. Similar trend was noticed in the histopathology analysis.
CONCLUSIONS: The results indicate that the novel catheter design significantly reduced SPCT rates, and was demonstrating proof of concept to our biomechanical approach.
You may also be interested in…
Weiss, D., Yaakobovitch, H., Tal, S., Nyska, A. and Rotman, O.M. (2018) Novel Short Peripheral Catheter Design for Prevention of Thrombophlebitis. Journal of Thrombosis and Haemostasis. December 2nd. .